Melatonin as COVID-19 treatment

Melatonin has been shown to play a role in viral infections and research suggests it may be an important adjunct to COVID-19 treatment
   
Data analysis by Cleveland Clinic found patients who used supplemental melatonin had a 28% lower risk of testing positive for COVID-19. Black people who used melatonin were 52% less likely to test positive for the virus
   
Melatonin attenuates several pathological features of COVID-19, including excessive inflammation and oxidation, exaggerated immune response resulting in a cytokine storm, acute lung injury and acute respiratory distress syndrome
   
A case series reports patients given 36 mg to 72 mg of intravenous melatonin per day as an adjunct therapy to standard of care improved within four to five days; all survived
   
Texas urgent care clinics using high-dose melatonin in combination with vitamin C and vitamin D say they’ve successfully treated hundreds of COVID-19 patients. Melatonin enhances vitamin D signaling and the two work synergistically to enhance your mitochondrial function

Read the full analysis by Dr. Mercola

 

 

George W. Bush: The terrorists want to change our lifestyle